• Markets
    • icon
  • Companies
NYR · ASX

Nyrada, Inc. Shs Chess Depository Interests Repr 1 Shs (ASX:NYR)

AU$0.055

 0.003 (5.769%)
ASX:Live
09/09/2024 04:10:50 PM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

NYR Overview

NYR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About NYR

Website

Nyrada, Inc. Shs Chess Depository Interests Repr 1 Shs

Telephone

N/A

Address

Description

N/A

NYR Price Chart

Key Stats

Market Cap

n/a

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.0

Trade Value (12mth)

N/A

1 week

-8.77%

1 month

20.93%

YTD

147.62%

1 year

100%

All time high

N/A

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Healthcare

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

N/A

Short Sell (% of issue)

N/A

NYR Announcements

Latest Announcements

Date Announcements

22 August 24

Preliminary final report

×

Preliminary final report

22 August 24

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

22 August 24

Annual Report for year ended 30 June 2024

×

Annual Report for year ended 30 June 2024

22 August 24

Full Year Results FY2024

×

Full Year Results FY2024

20 August 24

Brain Injury Program GLP Studies Further Update No 3

×

Brain Injury Program GLP Studies Further Update No 3

15 August 24

Investor Presentation

×

Investor Presentation

06 August 24

Brain Injury Program GLP Studies Further Update

×

Brain Injury Program GLP Studies Further Update

16 July 24

GLP Studies Update

×

GLP Studies Update

09 July 24

Nyrada Quarterly Activities Report & Appendix 4C

×

Nyrada Quarterly Activities Report & Appendix 4C

01 July 24

Notification of cessation of securities - NYR

×

Notification of cessation of securities - NYR

26 June 24

NYR Signs Strategic Partnership with US Brain Injury Company

×

NYR Signs Strategic Partnership with US Brain Injury Company

12 June 24

Application for quotation of securities - NYR

×

Application for quotation of securities - NYR

12 June 24

Cleansing Statement

×

Cleansing Statement

12 June 24

Notification regarding unquoted securities - NYR

×

Notification regarding unquoted securities - NYR

12 June 24

Change of Director's Interest Notice - ID

×

Change of Director's Interest Notice - ID

12 June 24

Change of Director's Interest Notice - RW

×

Change of Director's Interest Notice - RW

12 June 24

Change of Director's Interest Notice - MF

×

Change of Director's Interest Notice - MF

12 June 24

Change of Director's Interest Notice - JM

×

Change of Director's Interest Notice - JM

27 May 24

Upcoming Expiry of Unlisted Warrants

×

Upcoming Expiry of Unlisted Warrants

16 May 24

Nyrada General Meeting Results

×

Nyrada General Meeting Results

30 April 24

Nyrada Commences Walter Reed Traumatic Brain Injury Study

×

Nyrada Commences Walter Reed Traumatic Brain Injury Study

18 April 24

Investor Presentation - April 2024

×

Investor Presentation - April 2024

11 April 24

3QFY2024 Results and Investor Conference Call

×

3QFY2024 Results and Investor Conference Call

10 April 24

Quarterly Activities Report and Appendix 4C

×

Quarterly Activities Report and Appendix 4C

02 April 24

2024 EGM Notice of Meeting and Proxy

×

2024 EGM Notice of Meeting and Proxy

NYR Fundamentals

Per Share Records

Historical data

Forecast data

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) AU$ Lock Lock Lock Lock -0.03 -0.05 -0.01 Lock Lock Lock
EPS (Fully Diluted) AU$ Lock Lock Lock Lock -0.03 -0.05 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 15.6 -96.5 83.0 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS AU$ Lock Lock Lock Lock -0.02 -0.05 -0.01 Lock Lock Lock
FCFPS AU$ Lock Lock Lock Lock -0.02 -0.05 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -24.1 -142.3 87.9 Lock Lock Lock
     Yield % Lock Lock Lock Lock -14.0 -165.5 -7.9 Lock Lock Lock
DPS AU$ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS AU$ Lock Lock Lock Lock 0.07 0.03 0.03 Lock Lock Lock
BPS (Tangible) AU$ Lock Lock Lock Lock 0.07 0.03 0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock -20.7 -63.1 1.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 156 156 163 Lock Lock Lock
Basic m Lock Lock Lock Lock 156 156 163 Lock Lock Lock

Financial Records

Historical data

Forecast data

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses AU$m Lock Lock Lock Lock 5 9 5 Lock Lock Lock
Gross Income AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -163.3 -38.2 21.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBITDA AU$m Lock Lock Lock Lock -5 -9 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 13.3 -88.2 50.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Depreciation & Amortisation AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT AU$m Lock Lock Lock Lock -5 -9 -5 Lock Lock Lock
     Growth % Lock Lock Lock Lock 13.2 -88.2 50.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Pretax Income AU$m Lock Lock Lock Lock -5 -9 -5 Lock Lock Lock
Income Taxes AU$m Lock Lock Lock Lock -1 -1 -3 Lock Lock Lock
Net Income AU$m Lock Lock Lock Lock -4 -8 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -12.7 -96.7 82.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow AU$m Lock Lock Lock Lock -3 -7 -1 Lock Lock Lock
Capital Expenditures AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow AU$m Lock Lock Lock Lock 0 0 2 Lock Lock Lock
Free Cash Flow AU$m Lock Lock Lock Lock -3 -7 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -6.2 -146.1 89.4 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Franking Balance AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments AU$m Lock Lock Lock Lock 11 4 5 Lock Lock Lock
Total Assets AU$m Lock Lock Lock Lock 12 5 6 Lock Lock Lock
Long Term Debt AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt AU$m Lock Lock Lock Lock -11 -4 -5 Lock Lock Lock
Total Liabilities AU$m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
Equity AU$m Lock Lock Lock Lock 11 4 5 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 11 4 5 Lock Lock Lock
     Growth % Lock Lock Lock Lock -20.7 -63.0 18.6 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -33.1 -151.3 -23.5 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -34.6 -183.5 -27.4 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -37.4 -116.1 -98.0 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -30.6 -99.2 -29.8 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -22.6 -91.8 -16.4 Lock Lock Lock

Ratios Records

Historical data

Forecast data

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 2.2 0.4 1.0 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -94.1 -87.1 -94.4 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 25.4 5.8 7.0 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 25.4 5.8 7.0 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 90.4 72.3 81.2 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -621.4 -817.9 -91.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -33.1 -151.3 -23.5 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.0 1.2 1.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -34.6 -183.5 -27.4 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -34.6 -183.5 -27.4 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 5,858.7 15,869.6 22,121.2 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -5,858.7 -15,869.6 -22,121.2 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

%

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

NYR Shortsell

Frequently Asked Questions

The current share price of Nyrada, Inc. Shs Chess Depository Interests Repr 1 Shs (NYR:ASX) is AU$0.055.
The 52-week high share price for Nyrada, Inc. Shs Chess Depository Interests Repr 1 Shs (NYR:ASX) is AU$0.00.
The 52-week low share price for Nyrada, Inc. Shs Chess Depository Interests Repr 1 Shs (NYR:ASX)? is AU$0.00.
Nyrada, Inc. Shs Chess Depository Interests Repr 1 Shs (NYR:ASX) does not pay a dividend.
Nyrada, Inc. Shs Chess Depository Interests Repr 1 Shs (NYR:ASX) does not pay a dividend.
Nyrada, Inc. Shs Chess Depository Interests Repr 1 Shs (NYR:ASX) does not offer franking credits.
Nyrada, Inc. Shs Chess Depository Interests Repr 1 Shs (NYR:ASX) is classified in the Healthcare.
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.